These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18350343)

  • 1. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery.
    Botella-Carretero JI; Luque-Ramírez M; Alvarez-Blasco F; Peromingo R; San Millán JL; Escobar-Morreale HF
    Obes Surg; 2008 Aug; 18(8):1000-6. PubMed ID: 18350343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects.
    Hosseinzadeh-Attar MJ; Golpaie A; Janani L; Derakhshanian H
    Obes Facts; 2013; 6(2):193-202. PubMed ID: 23615494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery.
    Karbaschian Z; Hosseinzadeh-Attar MJ; Giahi L; Golpaie A; Masoudkabir F; Talebpour M; Kosari F; Karbaschian N; Hoseini M; Mazaherioun M
    Endocrine; 2013 Aug; 44(1):114-8. PubMed ID: 23104149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event.
    Botella-Carretero JI; Alvarez-Blasco F; Martinez-García MA; Luque-Ramírez M; San Millán JL; Escobar-Morreale HF
    Obes Surg; 2007 Sep; 17(9):1199-208. PubMed ID: 18074495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women.
    Auguet T; Terra X; Hernández M; Sabench F; Porras JA; Orellana-Gavaldà JM; Llutart J; Guiu-Jurado E; Berlanga A; Martinez S; Aguilar C; Castillo DD; Richart C
    Obesity (Silver Spring); 2014 Jan; 22(1):188-94. PubMed ID: 23554365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
    Nestvold TK; Nielsen EW; Lappegård KT
    Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference to assess reversal of insulin resistance following weight reduction after bariatric surgery: cohort and cross-sectional studies.
    Andersson DP; Wahrenberg H; Toft E; Qvisth V; Löfgren P; Hertel K; Leijonhufvud BM; Thorell A; Näslund E; Arner P
    Int J Obes (Lond); 2014 Mar; 38(3):438-43. PubMed ID: 23736362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in visfatin after weight loss induced by gastroplastic surgery.
    Krzyzanowska K; Mittermayer F; Krugluger W; Kopp HP; Schernthaner G
    Obesity (Silver Spring); 2006 Nov; 14(11):1886-9. PubMed ID: 17135602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass.
    García-Fuentes E; García-Almeida JM; García-Arnés J; García-Serrano S; Rivas-Marín J; Gallego-Perales JL; Rojo-Martínez G; Garrido-Sánchez L; Bermudez-Silva FJ; Rodríguez de Fonseca F; Soriguer F
    Obesity (Silver Spring); 2007 Oct; 15(10):2391-5. PubMed ID: 17925464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding.
    Haider DG; Schindler K; Schaller G; Prager G; Wolzt M; Ludvik B
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1578-81. PubMed ID: 16449335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.
    Pek SLT; Cheng AKS; Lin MX; Wong MS; Chan EZL; Moh AMC; Sum CF; Lim SC; Tavintharan S
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3029. PubMed ID: 29883055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients.
    Suwannasrisuk P; Boonchaya-Anant P; Houngngam N; Udomsawaengsup S; Sunthornyothin S
    BMC Endocr Disord; 2020 Apr; 20(1):45. PubMed ID: 32252748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
    Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.